140 related articles for article (PubMed ID: 6605800)
1. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
[TBL] [Abstract][Full Text] [Related]
2. Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.
Vánky F; Willems J; Kreicbergs A; Aparisi T; Andréen M; Broström LA; Nilsonne U; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):11-6. PubMed ID: 6605799
[TBL] [Abstract][Full Text] [Related]
3. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
[TBL] [Abstract][Full Text] [Related]
6. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
7. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
8. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
9. Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.
Vánky F; Stuber G; Willems J; Sjöwall K; Larsson B; Böök K; Ivert T; Péterffy A; Klein E
Cancer Immunol Immunother; 1988; 27(3):213-22. PubMed ID: 2972365
[TBL] [Abstract][Full Text] [Related]
10. Specific T-cell-mediated killing of autologous lung tumour cells.
Vose BM
Cell Immunol; 1980 Sep; 55(1):12-9. PubMed ID: 6968625
[No Abstract] [Full Text] [Related]
11. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Takenoyama M; Yoshino I; Eifuku R; So T; Imahayashi S; Sugaya M; Yasuda M; Inoue M; Ichiyoshi Y; Osaki T; Nagashima A; Nomoto K; Yasumoto K
Jpn J Cancer Res; 2001 Mar; 92(3):309-15. PubMed ID: 11267941
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
13. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
Han T; Takita H
Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
[No Abstract] [Full Text] [Related]
14. Functional characterization of T lymphocytes propagated from human lung carcinomas.
Kurnick JT; Kradin RL; Blumberg R; Schneeberger EE; Boyle LA
Clin Immunol Immunopathol; 1986 Mar; 38(3):367-80. PubMed ID: 3080265
[TBL] [Abstract][Full Text] [Related]
15. Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.
Takenoyama M; Yoshino I; Fujie H; Hanagiri T; Yoshimatsu T; Imabayashi S; Eifuku R; Nomoto K; Yasumoto K
Jpn J Cancer Res; 1998 Jan; 89(1):60-6. PubMed ID: 9510477
[TBL] [Abstract][Full Text] [Related]
16. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
[TBL] [Abstract][Full Text] [Related]
17. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Vánky F; Klein E
Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
[TBL] [Abstract][Full Text] [Related]
19. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
[TBL] [Abstract][Full Text] [Related]
20. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
